BioSpace News Archive

Modular Medical Inc. announced that Jeb Besser, the Company’s Chief Executive Officer, will be participating in the following investor conferences:

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference taking place September 12-14, 2022 in New York City.

Inscopix, Inc. announced that Kunal Ghosh, PhD, Chief Executive Officer of Inscopix, has been named to the PharmaVoice 100 — an annual list that recognizes the most inspiring people in the life-sciences industry.

SimBioSys, a technology company developing a first of its kind precision medicine platform, combining biophysical modeling and artificial intelligence, announced the appointment of Anant Madabhushi, PhD and Donald Berry, PhD to its scientific advisory board.

Adaptive Phage Therapeutics, Inc. announced “The AMR RAPID™ Challenge” at the World AMR Congress.

Kiyatec announced the company is sponsoring and exhibiting at the virtual American Brain Tumor Association 2022 National Conference September 9-10, 2022.

AMC Research is initiating a clinical trial for a promising new investigational treatment for Alzheimer’s disease (AD) in Matthews, N.C.

Artelo Biosciences, Inc. (Nasdaq: ARTL), today announced that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference which is being held September 12 - 14, 2022.

Nuvectis Pharma, Inc. announced that Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis, will present at the following investor conferences in September.

Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision medicine company with a novel, patented phosphoprotein-based assay for breast cancer, today announced that Mick Ruxin, M.D., President & CEO of Theralink, will participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022.